Great News! IVRS and Succipro Secure Eurostars Funding to Advance Next-Generation Treatment for Crohn’s Disease
We’re proud to share that IVRS AB and Succipro S.L. have received Eurostars funding to develop a new biologic therapy for Crohn’s disease, an important step toward more precise and effective treatments for inflammatory bowel disease (IBD). This collaboration brings together Succipro’s expertise in biologic drug development and IVRS’s advanced in vivo imaging capabilities, creating […]
IVRS and the NIAC Consortium Receive a Prestigious Eurostars Grant for Drug Development on Renal Cell Carcinoma
Exciting news! IVRS AB is proud to be a key partner in the NIAC consortium, recently awarded a €1.36M Eurostars grant for groundbreaking renal cell carcinoma (RCC) research! We’ll be leveraging our cutting-edge in vivo RCC models and whole-body 3D imaging to evaluate a novel inhibitor developed by AtG Therapeutics. This promising therapeutic could offer new hope for […]
